completed

STAGE Completes INR 4.2 Crore Liquidity Event 8 Early Employees Cash Out ESOPs After 6-Year Bet on Regional Content

STAGE, the OTT platform built for India's regional language audiences, has completed a INR 4.2 crore secondary transaction that allowed…

5 days ago

Pullman and Novotel New Delhi Aerocity Celebrate 10 years of Excellence

Marking ten years of elevating experiences, shaping culinary culture and leading Aerocity's growth story.NEW DELHI, Nov. 27, 2025 /PRNewswire/ -- Pullman…

3 weeks ago

MATHIEU JAMINET, PAULLOUP CHATIN COMPLETE GENESIS MAGMA RACINGS 2026 WEC DRIVER LINEUP

Genesis Magma Racing complete driver lineup for 2026 FIA World Endurance Championship with Mathieu Jaminet and Paul-Loup Chatin The two drivers…

4 weeks ago

JAMIE CHADWICK COMPLETES FIRST LAPS ABOARD GMR001 HYPERCAR

Jamie will serve as the team’s official Reserve Driver for the 2026 WEC season, as well as take on more…

4 weeks ago

LODD Completes First Flight of Hili – The UAE’s First Hybrid Heavy Cargo UAV, Designed, Built and Tested in Abu Dhabi

ABU DHABI, UAE, Nov. 13, 2025 /PRNewswire/ -- LODD Autonomous successfully completed the first flight of Hili, the UAE's first…

1 month ago

Torch Relay for the 15th National Games Kicks Off, with Feng Xingya, Chairman and President of GAC Group, Serving as Torchbearer

HONG KONG, Nov. 2, 2025 /PRNewswire/ -- On November 2, the torch relay for the 15th National Games, of the…

1 month ago

SiegFund Transforms Into SiegPath: A Strategic Rebrand Paving the Way for the Future of Professional Trading

SiegFund, a fintech–driven proprietary trading platform, has officially completed its brand upgrade and will now operate as SiegPath, serving proprietary traders…

2 months ago

Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania’s Green Future

As Shanghai Electric's fourth photovoltaic project in Romania, this initiative marks a major step forward for the country's clean energy…

2 months ago

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…

2 months ago

Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions

LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed…

2 months ago